Medical research

Cancer prevention drug also disables H. pylori bacterium

A medicine currently being tested as a chemoprevention agent for multiple types of cancer has more than one trick in its bag when it comes to preventing stomach cancer, Vanderbilt researchers have discovered.

Immunology

Toxin floats on lipid rafts

Helicobacter pylori, the leading cause of peptic ulcer disease and stomach cancer. One factor important to H. pylori infection is the pore-forming toxin VacA. It is thought to gain entry into host cells by binding to specialized ...

Oncology & Cancer

Does where you live impact stomach cancer risk?

It's estimated that nearly 28,000 new cases of stomach cancer will be diagnosed in the United States in 2017. The good news is that this incidence rate is significantly lower than it was in the early 1900s. Stomach cancer ...

page 8 from 16